EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineered Bacterial Outer Membrane Vesicles Hitchhiking on Neutrophils for Antibody Drug Delivery to Enhance Postoperative Immune Checkpoint Therapy

Meng Guan, Xiao-Ting Xie, Dong Zhou, Kai Cheng, Bin Zhang, Xin-Yue Xu, Yong Li, Yi-Tong Zhou, Wei Peng, Li-Li Chen, Peng-Shuo Dong, Si Chen und 4 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202505000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Meng Guan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Britton Chance Center for Biomedical Photonics at Wuhan National Laboratory for Optoelectronics - Hubei Bioinformatics & Molecular Imaging Key Labora…. Hauptthemen laut MEDLINE: Neutrophils, Immune Checkpoint Inhibitors, Immunotherapy, Bacterial Outer Membrane. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Bethune Charitable Foundation, Technology Innovation Program of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In clinical practice, surgical removal of tumors often leaves behind small tumors and circulating tumor cells, increasing the risk of metastasis and recurrence, which seriously affects treatment outcomes. Immunotherapy activates the immune system to monitor and inhibit tumor metastasis and recurrence long‐term. However, inflammatory microenvironments at surgical sites lead to immunosuppressive tumor‐associated macrophages (TAMs), causing immune evasion. Additionally, tumor cells overexpress the immune checkpoint CD47, further weakening the phagocytic and cytotoxic functions of macrophages. Here, the bacterial outer membrane vesicles (OMV) hitchhiking on neutrophils are utilized to precisely deliver immune checkpoint blockade antibodies to the tumor resection site. Escherichia coli is reprogrammed to express CD47 antibody and used to extract CD47 antibody‐containing OMV, followed by insertion of Ce6 photosensitizer into the membrane (OC47‐Ce6). Purified autologous neutrophils phagocytose and carry OC47‐Ce6 for precise targeting to the postoperative tumor resection site, mediating tumor cell killing, aCD47 release, and tumor‐associated antigen presentation by light. In vitro and in vivo experiments demonstrate that OC47‐Ce6 enhances TAM phagocytic function through TAM polarization and CD47 blockade. This approach effectively activates T‐cell anti‐tumor immune responses and significantly reduces the risk of postoperative tumor recurrence and metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeutrophilsImmune Checkpoint InhibitorsImmunotherapyBacterial Outer MembraneDrug Delivery SystemsNeoplasmsAnimalsMiceHumansCD47 AntigenCell Line, Tumor

Stichwörter der Autor:innen

engineered bacteriaimmunotherapyneutrophilsouter membrane vesicles

Substanzen

Immune Checkpoint InhibitorsCD47 Antigen

Autor:innen und Institutionen

  • Britton Chance Center for Biomedical Photonics at Wuhan National Laboratory for Optoelectronics - Hubei Bioinformatics & Molecular Imaging Key Laboratory, Department of Biomedical Engineering, College of Life Science an…
  • Department of Oncology, Huanggang Central Hospital of Yangtze University, Huanggang, Hubei, 438000, P. R. China.
  • Hubei Clinical Medical Research Center of Esophageal and Gastric Malignancy, Huanggang, Hubei, 438021, P.R. China.
  • Hubei Key Laboratory of Plasma Chemistry and Advanced Materials, School of Material Science and Engineering, Wuhan Institute of Technology, Wuhan, Hubei, 430205, P. R. China.
  • Key Laboratory of Biomedical Photonics (HUST), Ministry of Education, Huazhong University of Science and Technology, Wuhan, Hubei, 430074, P. R. China.

ORCID-Profile: Yuan-Di Zhao

Förderung

  • National Natural Science Foundation of China
  • Beijing Bethune Charitable Foundation
  • Technology Innovation Program of Hubei Province
  • Natural Science Foundation of Hubei Province of China

Zitieren

APA

Guan, M., Xie, X. T., Zhou, D., Cheng, K., Zhang, B., Xu, X. Y., Li, Y., Zhou, Y. T., Peng, W., Chen, L. L., Dong, P. S., Chen, S., Zou, J. H., Liu, B., Zhao, Y. D., & Fan, J. X. (2025). Engineered Bacterial Outer Membrane Vesicles Hitchhiking on Neutrophils for Antibody Drug Delivery to Enhance Postoperative Immune Checkpoint Therapy. Advanced Science. https://doi.org/10.1002/advs.202505000

Vancouver

Guan M, Xie XT, Zhou D, Cheng K, Zhang B, Xu XY, et al. Engineered Bacterial Outer Membrane Vesicles Hitchhiking on Neutrophils for Antibody Drug Delivery to Enhance Postoperative Immune Checkpoint Therapy. Advanced Science. 2025. doi:10.1002/advs.202505000

BibTeX
@article{Guan2025,
  author = {Guan, Meng and Xie, Xiao-Ting and Zhou, Dong and Cheng, Kai and Zhang, Bin and Xu, Xin-Yue and Li, Yong and Zhou, Yi-Tong and Peng, Wei and Chen, Li-Li and Dong, Peng-Shuo and Chen, Si and Zou, Jia-Hua and Liu, Bo and Zhao, Yuan-Di and Fan, Jin-Xuan},
  title = {Engineered Bacterial Outer Membrane Vesicles Hitchhiking on Neutrophils for Antibody Drug Delivery to Enhance Postoperative Immune Checkpoint Therapy},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202505000}
}
Kostenlos starten →